TypeZyme A

Food supplement declared in France, decision dated 18 April 2025

TypeZyme A (North American Pharmacal) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand: North American Pharmacal
Food business operator placing the product on the market: Karen Vago
Status: Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form: Gélule
Daily dose: 2
Directions for use: Prendre 1 gélule au déjeuner et au diner avec le repas.
Intended populations: Hommes et femmes de 18 ans et plus
Objectives stated by the manufacturer (these are not authorised claims): Digestion, Transit

Declaration 259163, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

Plant	Part	Preparation	Per day
Cynara scolymus L.	Feuille	Poudre (de plantes séchées ou broyées)	4 mg

Substances

Name	Per day
protéase	260 mg
lipase	200 mg
bromélaïne	200 mg

Other active ingredients

Name	Per day
Chlorhydrate de bétaïne	not declared

Additives

E460

List from the declaration, administrative decision dated 18 April 2025 (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : North American Pharmacal